Article Text

PDF

Potassium clorazepate (Tranxene)-induced jaundice
  1. J. L. W. Parker

    Abstract

    A first report of jaundice and hepatic necrosis probably due to potassium clorazepate is described. The histology is discussed and it is suggested that the drug should not be given in the presence of suspected hepatic dysfunction.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.